FDA.reportPublic FDA data

deutivacaftor 50 MG / tezacaftor 20 MG / vanzacaftor 4 MG Oral Tablet [Alyftrek]

RxCUI
2701450
RxNorm name
deutivacaftor 50 MG / tezacaftor 20 MG / vanzacaftor 4 MG Oral Tablet [Alyftrek]
Display name
deutivacaftor 50 MG / tezacaftor 20 MG / vanzacaftor 4 MG Oral Tablet [Alyftrek]
Full name
deutivacaftor 50 MG / tezacaftor 20 MG / vanzacaftor 4 MG Oral Tablet [Alyftrek]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ALYFTREKVANZACAFTOR, TEZACAFTOR, AND DEUTIVACAFTORVertex Pharmaceuticals Incorporated7e635909-c6fd-4f0d-ae77-cdff03653a202026-08-26Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2701450

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7e635909-c6fd-4f0d-ae77-cdff03653a20alyftrek 50 MG / 20 MG / 4 MG Oral Tablet [PSN] · deutivacaftor 50 MG / tezacaftor 20 MG / vanzacaftor 4 MG Oral Tablet [Alyftrek] [SBD] · Alyftrek 50 MG / 20 MG / 4 MG (equivalent to vanzacaftor calcium dihydrate 4.24 MG) Oral Tablet [SY]38These highlights do not include all the information needed to use ALYFTREK safely and effectively. See full prescribing information for ALYFTREK. ALYFTREK (vanzacaftor, tezacaftor, and deutivacaftor tablets), for oral use Initial U.S. Approval: 202420260323